Based on the pathophysiological and clinical characteristics of N-ERD, anti-IL 5 therapy may be effective in this patient subgroup.
The GOLD Report includes key recommendations for personalizing treatment in stable COPD as well as guidelines for managing exacerbations.
ACR 2019, News
Researchers evaluated the efficacy and safety of guselkumab in patients with active psoriatic arthritis who were biologic-naive or treated with prior tumor necrosis factor inhibitors.
The most recent guidelines from the American College of Rheumatology
include pharmacologic and nonpharmacologic therapy for hyperuricemia.
The Global Initiative for Asthma (GINA)'s 2012 Guidelines provides a stepwise plan for treatment of asthma, based on disease severity.
Patient Fact Sheets
This patient information fact sheet provides information on the definition, causes, symptoms, diagnostic tests, and treatments for multiple sclerosis.
Asthma management chart for children 0-4 years of age.
Asthma management chart for children 5-11 years of age.
Both the 60- and 120-actuation sizes have been discontinued.
Drugs in the Pipeline
Acton announced that it has submitted a supplemental New Drug Application (sNDA) to the FDA for its new asthma product, Aerospan (flunisolide HFA, 80 mcg) Inhalation Aerosol.